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150 kDa caldesmon was shown to be characteristic of vascular smooth muscle cells in normal tissue rather 
than in subculture. Subcultured smooth muscle cells from human aorta contained only the 70 kDa immu- 
noreactive form of caldesmon. During the course of primary culture the amount of 150 kDa caldesmon 
as well as metavinculin decreased significantly whilst 70 kDa caldesmon became the predominant form, and 
by the onset of cell division the 150 kDa form was practically substituted by 70 kDa caldesmon. The data 
show that the predominance of 150 kDa caldesmon is characteristic of contractile smooth muscle cells, while 
in proliferating cells 70 kDa caldesmon is expressed. 
Caldesmon; Phenotypic modulation; (Smooth muscle) 
1. INTRODUCTION 
During the course of primary culture, smooth 
muscle cells undergo ‘phenotypic modulation’ [ 11, 
which includes an increase in proliferative, syn- 
thetic and secretory activity, and rearrangement of 
the cytoskeleton and contractile apparatus. A 
definite shift to the expression of non-muscle 
forms and isoforms of contractile and cytoskeletal 
proteins during cultivation has been demonstrated: 
desmin is replaced by vimentin; the amount of 
smooth muscle cu-actin is decreased significantly 
whilst ,&-actin becomes the major actin isoform [2]; 
the amount of meta-vinculin, a vinculin-related 
protein, becomes negligible by the onset of cell 
division in primary culture [3]. These in vitro 
changes are believed to be relevant to the process 
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of phenotypic modulation which occurs in vivo 
during the development of certain diseases involv- 
ing the vascular wall (atherosclerosis, hyper- 
tension). 
Caldesmon is an F-actin- and calmodulin- 
binding protein found in all smooth muscle and 
non-muscle cells examined so far [4-61. It is con- 
sidered to be involved in the regulation of actin- 
myosin interactions. Two immunoreactive forms 
of caldesmon are found in tissues and cells, namely 
those of 120-150 and 71-77 kDa [5]. Both forms 
are capable of interacting with Ca2+-calmodulin 
and F-actin. In smooth muscle cells 150 kDa 
caldesmon rather than the 70 kDa form was 
revealed [7]. 
Here, we identify immunoreactive forms of 
caldesmon in smooth muscle cells from human 
aorta in primary culture and subculture, and show 
that the 150 kDa form, found in smooth muscle 
cells isolated from normal tissue by enzyme diges- 
tion, by the onset of cell division in primary culture 
is practically substituted by the 70 kDa form 
characteristic of subcultured cells. 
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2. MATERIALS AND METHODS 
Cells from tunica intima of human aorta were 
isolated by collagenase-elastase digestion [8,9] and 
cultivated as in [lo]. Tissue samples were obtained 
at autopsies taken within 3 h of death. Foreskin 
fibroblasts (10th passage) were isolated and 
cultivated according to [ll]. Human peritoneal 
macrophages were isolated from ascites fluid ob- 
tained from a patient suffering from heart failure. 
Vinculin and filamin for immunization were 
purified from human uterus according to [12] and 
caldesmon as described in [ 131. Antibodies raised 
in rabbits were shown to be monospecific as 
judged by immunoblotting performed with uterus 
extract. IgG fractions were obtained by (NH&S04 
precipitation followed by DEAE chromatography. 
Cells or tissue samples were lysed using 40 mM 
Tris-HCI buffer, pH 8.0, containing 5% /?- 
mercaptoethanol, 4% SDS, 10 mM EDTA, 20070 
glycerol, 2 mM PMSF, 20pg/ml each of leupep- 
tin, pepstatin and aprotinin and 130 /cg/ml of ben- 
zamidine. Extracts were run in 5-15% 
SDS-polyacrylamide slab gels. Immunoblotting 
was performed as described [141. Each sample con- 
tained an extract of 5-7 x 10’ cells. Anti- 
caldesmon IgG (4 mg/ml) were diluted down to 
150 pg/ml, anti-vinculin (10 mg/ml) to 70 pg/ml 
and anti-filamin (2 mg/ml) to 40pg/ml. i2’I- 
labeled goat anti-rabbit IgG (IO6 cpm/pg, 
lOpg/ml) were used as secondary antibody. Im- 
munoblots were exposed to X-ray film (Tasma, 
USSR) overnight. The method was reproducible 
with repeated measurements on the same sample 
and was linear over the range of protein loadings 
used. 
3. RESULTS AND DISCUSSION 
To determine the amount of filamin, meta- 
vinculin, vinculin and the two immunoreactive 
forms of caldesmon (150 and 70 kDa) in cultivated 
smooth muscle cells we used a quantitative im- 
munoblotting technique. Since the high-molecular- 
mass forms of caldesmon and meta-vinculin have 
very similar electrophoretic mobility, two aliquots 
of the same cell extract were analyzed separately to 
reveal both proteins. After the samples underwent 
electrophoresis and the proteins transferred onto 
nitrocellulose, the blots were cut into two parts, 
the upper ones being further treated with anti- 
A 
Fig. 1. Relative quantitative determination of filamin, 
meta-vinculin, vinculin and the two immunoreactive 
forms of caldesmon in cultivated smooth muscle cells 
from tunica intima of human aorta. (A) Autoradiograph 
of an immunoblot revealing filamin, meta-vinculin and 
vinculin. The upper part of the nitrocellulose strip was 
treated with anti-filamin primary antibody, the lower 
part with anti-vinculin antibody to reveal meta-vinculin 
and vinculin. Both parts of the blot were then treated 
with 12’I-secondary antibody and exposed to X-ray film. 
The positions of purified proteins in the gel are indicated 
by the lines (from top to bottom): filamin, 250 kDa; 
meta-vinculin, 150 kDa; vinculin, 130 kDa. Values 
beneath the autoradiograph correspond to the 
cultivation time in days. (B) The strips of nitrocellulose, 
corresponding to filamin, meta-vinculin and vinculin 
were cut out and counted: (A---A)’ filamin, (M) 
meta-vinculin, (o--i)) vinculin. (C) Autoradiograph of 
immunoblot revealing filamin, and the 150 kDa and 
70 kDa immunoreactive forms of caldesmon. The same 
as in A, but the lower part of the blot was treated with 
anti-caldesmon primary antibody. The positions of 
purified proteins in the gel are indicated by the lines 
(from top to bottom): filamin, 250 kDa; caldesmon, 
150 kDa; caldesmon, 70 kDa. (D) The strips of 
nitrocellulose, corresponding to filamin, and the 
150 kDa and 70 kDa forms of caldesmon were cut out 
and counted: (A---A) filamin, (o--o) 150 kDa 
caldesmon, (C--O) 70 kDa caldesmon. 
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filamin antibodies (fig.lA,C) and the lower with 
anti-vinculin (fig. 1A) or with anti-caldesmon an- 
tibodies (fig. 1 C). The data presented in fig. 1A and 
B show that the absolute amounts of filamin as 
well as vinculin in different samples remained 
practically constant whereas, as demonstrated 
earlier [3], the amount of meta-vinculin decreased 
during cultivation and by the 10th day (onset of in- 
tensive cell division) the protein could hardly be 
detected. 
In cells isolated from human aorta tunica media 
and tunica intima 150 kDa caldesmon was 
predominant, if not the only immunoreactive form 
of the protein revealed. 70 kDa caldesmon was 
detected only in some samples and, if at all pre- 
sent, could account for only lo-25010 of the total 
(150 kDa + 70 kDa) immunoreactive caldesmon 
Fig.2. Identification of immunoreactive forms of 
caldesmon i tunica media and tunica intima of human 
aorta and cultivated cells. Lanes: 1, tunica intima of 
human aorta; 2, tunica media of human aorta; 3, 
smooth muscle cells from tunica media of human aorta, 
5th passage; 4, human foreskin fibroblasts, 10th 
passage; 5, human peritoneal macrophages. Secondary 
antibodies were peroxidase-conjugated. cu-Chloro- 
naphthol was used as a substrate for peroxidase. 
Positions of purified caldesmon (150 kDa and 70 kDa) 
are indicated by the lines. 
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(fig.lC,D). On the 3rd day of cultivation, i.e. 
when the cells had just finished spreading, they 
already contained even more 70 kDa than 150 kDa 
caldesmon, and by the 10th day the amount of 
150 kDa caldesmon decreased about lo-fold. The 
results suggest that the predominance of the 
150 kDa form is characteristic of contractile 
smooth muscle cells, while the 70 kDa form is ex- 
pressed in proliferating cells. Thus, the loss of 
meta-vinculin and the switch in the immunoreac- 
tive caldesmon pattern indicate rearrangement of 
the cytoskeleton and contractile apparatus, accom- 
panying phenotypic modulation of vascular 
smooth muscle cells in culture. 
Subcultured vascular smooth muscle cells (fig.2) 
as well as other cultivated cells, foreskin 
fibroblasts and macrophages, contained only trace 
amounts of 150 kDa caldesmon, if any. 
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